PTEN loss has been reported as a potentially useful marker to distinguish IDC-P from high-grade prostatic intraepithelial neoplasia (PIN) by immunostaining in biopsy specimens with significant clinical implications23. Here, PTEN is linked to prostate intraepithelial neoplasia.